Clinical Study of Perinatal Hysterectomy Between 2000-2011 in the Clinic of Obstetrics, Gynecological Diseases and Oncological Gynecology in Bydgoszcz

Jagielska, Iwona; Kazdepka-Ziemińska, Anita; Tyloch, Małgorzata; Papierski, Maciej; Żołnieżewicz, Krzysztof; Grabiec, Marek; Szymánski, W

doi:10.17772/gp/1712

Cited by 5 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Placenta accrete spectrum (PAS) is a life threatening condition, which is, now, becoming an emerging cause of obstetric haemorrhage. It is the most frequent indication of peripartum hysterectomy [1,2] . Placenta accrete spectrum, formerly called as morbid adherent placenta, collectively includes placenta accreta, placenta increta and placenta percreta.…”

Section: Introductionmentioning

confidence: 99%

Placenta accrete spectrum-management and fetomaternal outcome at a tertiary care centre

Rani¹,

Jain²,

Nanda³

et al. 2019

Int. J. Clin. Obstet. Gynaecol.

View full text Add to dashboard Cite

The aim of this study was to evaluate the demographic profile, risk factors, management strategies in women with placenta accrete spectrum and also to see the feto-maternal outcome of these women. Study design-Prospective AnalysisMethods: This study was conducted in the Department of Obstetrics and Gynaecology, PGIMS, Rohtak, Haryana from January 2017 to December 2018. All the women who were diagnosed as placenta accrete spectrum (PAS) either on ultrasonography, magnetic resonance imaging or intra-operatively were included in the study. Results: During the two year study period, there were 22745 deliveries, out of which 22 patients were diagnosed to have placenta accrete spectrum, therefore, the incidence was 0.09%. The majority (41%) of the women in study belonged to the age group of 30-35 years. Most of the women (77%) were unbooked and 80% were from rural background. None of the women in our study were primiparous. The risk factors for PAS in our study included history of one caesarean section in 11(50%) patients, two caesarean section in 4 (18%) patients and history of three caesarean section in 2 (9%) patients. Co-existing placenta previa was present in 17 (77%) of the women with placenta accrete spectrum. Eight women (36%) had placenta accrete, one (5%) had placenta increta and rest of the 59% were diagnosed as placenta percreta. The maternal complications encountered in the study were post-partum haemorrhage (95%), bladder injury (59%), DIC (9%) and sepsis (5%). Maternal mortality rate was 9%. The most common neonatal complication was prematurity and low birth weight. Conclusion:The rising rates of caesarean sections is an important factor behind increase in incidence of placenta accrete spectrum. Early diagnosis in antenatal period, timely intervention, multi-disciplinary team approach and adequate arrangement of blood and blood products is a key for successful management of PAS, thereby, reducing maternal and neonatal morbidity and mortality.

show abstract

Section: Introductionmentioning

confidence: 99%

Placenta accrete spectrum-management and fetomaternal outcome at a tertiary care centre

Rani¹,

Jain²,

Nanda³

et al. 2019

Int. J. Clin. Obstet. Gynaecol.

View full text Add to dashboard Cite

show abstract

“…Once a rare occurrence, morbidly adherent placenta is now becoming an increasingly common complication of pregnancy, mainly due to the increasing rate of Caesarean delivery over the past 50 years [4]. It is the most frequent indication for peripartum hysterectomy [5][6][7]. It addition, the incidence of perinatal complications is also increased due to preterm birth and small for gestational age foetuses [8,9].…”

Section: Introductionmentioning

confidence: 99%

Morbidly Adherent Placenta: Its Management and Maternal and Perinatal Outcome

Chaudhari

Shah

D’Souza

2016

J Obstet Gynecol India

View full text Add to dashboard Cite

Objectives The aim of the study was to identify the risk factors predisposing to morbidly adherent placenta and to study the different modes of management and the obstetric and neonatal outcome of these patients. Methods This was a retrospective cum prospective observational study conducted in the Department of Obstetrics and Gynaecology in a tertiary care referral hospital in Mumbai from January 2012 to November 2014. Results The incidence of morbidly adherent placenta was 1.32 per 1000 pregnancies with patient profile comprising second gravida in the age group 26-28 years; 90 % of the patients in this study had previous Caesarean section and co-existing placenta praevia was diagnosed in 63 %. Fiftythree per cent of the women delivered between 35 and 38 weeks and 40 % had elective deliveries. Caesarean section was the mode of delivery in 90 % of the patients. 123Prophylactic balloon placement in the internal iliac artery followed by classical Caesarean section, uterine artery embolization and post-operative methotrexate was done in 27 % which preserved the uterus and was associated the blood loss of 1000-2000 mL. Conclusion Antenatal diagnosis of morbidly adherent placenta allows for multidisciplinary planning in an attempt to minimize potential maternal or neonatal morbidity and mortality.

show abstract

“…MAP is becoming a more common pregnancy complication, owing to an increase in the rate of C/S during the last 50 years (11) . It is the most frequent indication for peripartum hysterectomy (12) . Furthermore, preterm birth and fetuses that are small for gestational age increase the risk of perinatal problems (13) .…”

Section: Discussionmentioning

confidence: 99%

Maternal Serum Alpha Feto Protein Level May Predict Morbidly Adherent Placenta in Women with Placenta Previa

Hassan,

Ghalib

2022

IraqiJMS

View full text Add to dashboard Cite

Background: In situations of a morbidly adherent placenta, studies have shown that maternal serum alfa feto protein (AFP) is clinically high. Objective: To examine the association of morbidly adherent placenta (MAP) in pregnant women with placenta previa (PP) and their serum AFP biomarker. Methods: A prospective observational study that was conducted in the Department of Obstetrics and Gynecology at Azadi Teaching Hospital, Kirkuk, Iraq during the period from Feb. till Nov. 2019. It included 82 pregnant women those between 14-20 weeks of gestation with singleton pregnancy, viable fetus, and diagnosed with low lying placenta, with and without vaginal bleeding. A blood sample from all women was taken to investigate for serum AFP level after confirming the diagnosis of low-lying placenta by early abdominal ultrasound (U/S) scan. All the enrolled pregnant women were followed by Doppler U/S at gestational age 28-32 weeks, underwent targeted screening for MAP and were divided into two groups according to the status of placenta: MAP group included 11 pregnant women and PP group alone included 71 pregnant women. Results: In this study, MAP was diagnosed in 13.4% of cases. Mean of serum AFP biomarker in women with MAP was significantly higher than that in women with PP. Serum AFP biomarker in early pregnancy >200 ng/ml is predictive for diagnosis of MAP in late pregnancy. Conclusion: Maternal serum AFP biomarker may play an important role at early pregnancy in prediction of placental adherence at late pregnancy in cases of early low-lying placenta. Keywords: Morbidly adherent placenta, alpha feto protein, previa, pregnancy, Iraq Citation: Hassan SS, Ghalib AK. Maternal serum alpha feto protein level may predict morbidly adherent placenta in women with placenta previa. Iraqi JMS. 2022; 20(2): 278-285. doi: 10.22578/IJMS.20.2.16

show abstract

Clinical Study of Perinatal Hysterectomy Between 2000-2011 in the Clinic of Obstetrics, Gynecological Diseases and Oncological Gynecology in Bydgoszcz

Cited by 5 publications

References 0 publications

Placenta accrete spectrum-management and fetomaternal outcome at a tertiary care centre

Placenta accrete spectrum-management and fetomaternal outcome at a tertiary care centre

Morbidly Adherent Placenta: Its Management and Maternal and Perinatal Outcome

Maternal Serum Alpha Feto Protein Level May Predict Morbidly Adherent Placenta in Women with Placenta Previa

Contact Info

Product

Resources

About